Global Long Read Sequencing Size, Share, Trends & Forecast 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Long Read Sequencing Market Size Analysis

Global Long Read Sequencing Market Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing (SMRT)
  1. By Value
3. Nanopore Sequencing
  1. By Value
By Product and Services
1. Introduction
  1. Product and Services By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Identification and Fine Mapping of Structural Variation
  1. By Value
3. Cancer
  1. By Value
4. Viral and Microbial Sequencing
  1. By Value
5. Reproductive Genomics
  1. By Value
6. Tandem Repeat Sequencing
  1. By Value
7. Resolving allele phasing
  1. By Value
By Work Flow
1. Introduction
  1. Work Flow By Value
2. Sequencing
  1. By Value
3. Pre-Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Clinical Research
  1. By Value
3. Academic Research
  1. By Value
4. Pharma and Biotech Entities
  1. By Value
5. Hospitals and Clinics
  1. By Value

North America Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing (SMRT)
  1. By Value
3. Nanopore Sequencing
  1. By Value
By Product and Services
1. Introduction
  1. Product and Services By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Identification and Fine Mapping of Structural Variation
  1. By Value
3. Cancer
  1. By Value
4. Viral and Microbial Sequencing
  1. By Value
5. Reproductive Genomics
  1. By Value
6. Tandem Repeat Sequencing
  1. By Value
7. Resolving allele phasing
  1. By Value
By Work Flow
1. Introduction
  1. Work Flow By Value
2. Sequencing
  1. By Value
3. Pre-Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Clinical Research
  1. By Value
3. Academic Research
  1. By Value
4. Pharma and Biotech Entities
  1. By Value
5. Hospitals and Clinics
  1. By Value
U.S.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing (SMRT)
    1. By Value
  3. Nanopore Sequencing
    1. By Value
2. By Product and Services
  1. Introduction
    1. Product and Services By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Identification and Fine Mapping of Structural Variation
    1. By Value
  3. Cancer
    1. By Value
  4. Viral and Microbial Sequencing
    1. By Value
  5. Reproductive Genomics
    1. By Value
  6. Tandem Repeat Sequencing
    1. By Value
  7. Resolving allele phasing
    1. By Value
4. By Work Flow
  1. Introduction
    1. Work Flow By Value
  2. Sequencing
    1. By Value
  3. Pre-Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Clinical Research
    1. By Value
  3. Academic Research
    1. By Value
  4. Pharma and Biotech Entities
    1. By Value
  5. Hospitals and Clinics
    1. By Value
Canada

Europe Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing (SMRT)
  1. By Value
3. Nanopore Sequencing
  1. By Value
By Product and Services
1. Introduction
  1. Product and Services By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Identification and Fine Mapping of Structural Variation
  1. By Value
3. Cancer
  1. By Value
4. Viral and Microbial Sequencing
  1. By Value
5. Reproductive Genomics
  1. By Value
6. Tandem Repeat Sequencing
  1. By Value
7. Resolving allele phasing
  1. By Value
By Work Flow
1. Introduction
  1. Work Flow By Value
2. Sequencing
  1. By Value
3. Pre-Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Clinical Research
  1. By Value
3. Academic Research
  1. By Value
4. Pharma and Biotech Entities
  1. By Value
5. Hospitals and Clinics
  1. By Value
U.K.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing (SMRT)
    1. By Value
  3. Nanopore Sequencing
    1. By Value
2. By Product and Services
  1. Introduction
    1. Product and Services By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Identification and Fine Mapping of Structural Variation
    1. By Value
  3. Cancer
    1. By Value
  4. Viral and Microbial Sequencing
    1. By Value
  5. Reproductive Genomics
    1. By Value
  6. Tandem Repeat Sequencing
    1. By Value
  7. Resolving allele phasing
    1. By Value
4. By Work Flow
  1. Introduction
    1. Work Flow By Value
  2. Sequencing
    1. By Value
  3. Pre-Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Clinical Research
    1. By Value
  3. Academic Research
    1. By Value
  4. Pharma and Biotech Entities
    1. By Value
  5. Hospitals and Clinics
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing (SMRT)
  1. By Value
3. Nanopore Sequencing
  1. By Value
By Product and Services
1. Introduction
  1. Product and Services By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Identification and Fine Mapping of Structural Variation
  1. By Value
3. Cancer
  1. By Value
4. Viral and Microbial Sequencing
  1. By Value
5. Reproductive Genomics
  1. By Value
6. Tandem Repeat Sequencing
  1. By Value
7. Resolving allele phasing
  1. By Value
By Work Flow
1. Introduction
  1. Work Flow By Value
2. Sequencing
  1. By Value
3. Pre-Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Clinical Research
  1. By Value
3. Academic Research
  1. By Value
4. Pharma and Biotech Entities
  1. By Value
5. Hospitals and Clinics
  1. By Value
China
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing (SMRT)
    1. By Value
  3. Nanopore Sequencing
    1. By Value
2. By Product and Services
  1. Introduction
    1. Product and Services By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Identification and Fine Mapping of Structural Variation
    1. By Value
  3. Cancer
    1. By Value
  4. Viral and Microbial Sequencing
    1. By Value
  5. Reproductive Genomics
    1. By Value
  6. Tandem Repeat Sequencing
    1. By Value
  7. Resolving allele phasing
    1. By Value
4. By Work Flow
  1. Introduction
    1. Work Flow By Value
  2. Sequencing
    1. By Value
  3. Pre-Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Clinical Research
    1. By Value
  3. Academic Research
    1. By Value
  4. Pharma and Biotech Entities
    1. By Value
  5. Hospitals and Clinics
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing (SMRT)
  1. By Value
3. Nanopore Sequencing
  1. By Value
By Product and Services
1. Introduction
  1. Product and Services By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Identification and Fine Mapping of Structural Variation
  1. By Value
3. Cancer
  1. By Value
4. Viral and Microbial Sequencing
  1. By Value
5. Reproductive Genomics
  1. By Value
6. Tandem Repeat Sequencing
  1. By Value
7. Resolving allele phasing
  1. By Value
By Work Flow
1. Introduction
  1. Work Flow By Value
2. Sequencing
  1. By Value
3. Pre-Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Clinical Research
  1. By Value
3. Academic Research
  1. By Value
4. Pharma and Biotech Entities
  1. By Value
5. Hospitals and Clinics
  1. By Value
UAE
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing (SMRT)
    1. By Value
  3. Nanopore Sequencing
    1. By Value
2. By Product and Services
  1. Introduction
    1. Product and Services By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Identification and Fine Mapping of Structural Variation
    1. By Value
  3. Cancer
    1. By Value
  4. Viral and Microbial Sequencing
    1. By Value
  5. Reproductive Genomics
    1. By Value
  6. Tandem Repeat Sequencing
    1. By Value
  7. Resolving allele phasing
    1. By Value
4. By Work Flow
  1. Introduction
    1. Work Flow By Value
  2. Sequencing
    1. By Value
  3. Pre-Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Clinical Research
    1. By Value
  3. Academic Research
    1. By Value
  4. Pharma and Biotech Entities
    1. By Value
  5. Hospitals and Clinics
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing (SMRT)
  1. By Value
3. Nanopore Sequencing
  1. By Value
By Product and Services
1. Introduction
  1. Product and Services By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Identification and Fine Mapping of Structural Variation
  1. By Value
3. Cancer
  1. By Value
4. Viral and Microbial Sequencing
  1. By Value
5. Reproductive Genomics
  1. By Value
6. Tandem Repeat Sequencing
  1. By Value
7. Resolving allele phasing
  1. By Value
By Work Flow
1. Introduction
  1. Work Flow By Value
2. Sequencing
  1. By Value
3. Pre-Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Clinical Research
  1. By Value
3. Academic Research
  1. By Value
4. Pharma and Biotech Entities
  1. By Value
5. Hospitals and Clinics
  1. By Value
Brazil
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing (SMRT)
    1. By Value
  3. Nanopore Sequencing
    1. By Value
2. By Product and Services
  1. Introduction
    1. Product and Services By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Identification and Fine Mapping of Structural Variation
    1. By Value
  3. Cancer
    1. By Value
  4. Viral and Microbial Sequencing
    1. By Value
  5. Reproductive Genomics
    1. By Value
  6. Tandem Repeat Sequencing
    1. By Value
  7. Resolving allele phasing
    1. By Value
4. By Work Flow
  1. Introduction
    1. Work Flow By Value
  2. Sequencing
    1. By Value
  3. Pre-Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Clinical Research
    1. By Value
  3. Academic Research
    1. By Value
  4. Pharma and Biotech Entities
    1. By Value
  5. Hospitals and Clinics
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Long Read Sequencing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Illumina, Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
MicrobesNG
Stratos Genomics (Hoffmann-La Roche Ltd.)
Pacific Biosciences of California, Inc.
Oxford Nanopore
Quantapore, Inc.
FG Technologies
BaseClear B.V
Institute of Integrative Cell Biology
The Garvan Institute of Medical Research
The Bordeaux Transcriptome Genome Platform
Takara Bio Inc. (Takara Holdings Inc.)
Genexa AG

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment